News FDA puts hold on AZ and Celgene immunotherapy trials Regulator is exploring safety of immunotherapy combinations in blood cancer
News FDA halts recruitment to three BMS Opdivo trials FDA is investigating safety of immunotherapies in blood cancer.
News AZ and Merck & Co ovarian cancer drug gets expanded US use FDA approves Lynparza's use in a wider group of women.
News Trump disbands business forums as CEOs quit J&J's CEO Gorsky also quit before Trump axed councils
News BMS shares fall after latest Opdivo disappointment BMS waiting for overall survival data of Opdivo and Yervoy in kidney cancer
News Merck's Frazier resigns from Trump council Trump rage-tweets following Kenneth Frazier's resignation.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
